Mereo BioPharma Group plc, a clinical stage biopharmaceutical company focused on oncology and rare diseases, has appointed Christine Fox, CPA, as chief financial officer (CFO) and Heidi Petersen as senior vice president, regulatory affairs.   “Christine and Heidi are seasoned financial and regulatory executives and we are excited to welcome them to Mereo. The remainder of 2020 and 2021 will be an important period for Mereo as we expect multiple milestones across our pipeline, including the initi...